Follow
Sladana Zagorac
Title
Cited by
Cited by
Year
Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy
E Lonardo, PC Hermann, MT Mueller, S Huber, A Balic, ...
Cell stem cell 9 (5), 433-446, 2011
4482011
Intracellular autofluorescence: a biomarker for epithelial cancer stem cells
I Miranda-Lorenzo, J Dorado, E Lonardo, S Alcala, AG Serrano, ...
Nature methods 11 (11), 1161-1169, 2014
2202014
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
S Ottaviani, J Stebbing, AE Frampton, S Zagorac, J Krell, A de Giorgio, ...
Nature communications 9 (1), 1845, 2018
1132018
DNMT1 inhibition reprograms pancreatic cancer stem cells via upregulation of the miR-17-92 cluster
S Zagorac, S Alcala, G Fernandez Bayon, T Bou Kheir, M Schoenhals, ...
Cancer research 76 (15), 4546-4558, 2016
1092016
Circulating microRNAs in small-bowel neuroendocrine tumors: a potential tool for diagnosis and assessment of effectiveness of surgical resection
A Malczewska, AE Frampton, MM Prado, S Ameri, AF Dabrowska, ...
Annals of surgery 274 (1), e1-e9, 2021
302021
Managing patients with cancer in the COVID-19 era
L Peng, S Zagorac, J Stebbing
European Journal of cancer 132, 5-7, 2020
232020
SCIRT lncRNA restrains tumorigenesis by opposing transcriptional programs of tumor-initiating cells
S Zagorac, A de Giorgio, A Dabrowska, M Kalisz, N Casas-Vila, ...
Cancer Research 81 (3), 580-593, 2021
212021
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma
MP de Andrés, RJ Jackson, I Felipe, S Zagorac, C Pilarsky, AM Schlitter, ...
Gut 72 (3), 535-548, 2023
142023
Bcl3 couples cancer stem cell enrichment with pancreatic cancer molecular subtypes
J Ai, SM Wörmann, K Görgülü, M Vallespinos, S Zagorac, S Alcala, N Wu, ...
Gastroenterology 161 (1), 318-332. e9, 2021
82021
The epigenetic landscape of pancreatic cancer stem cells
S Zagorac, L Garcia-Bermejo, B Sainz Jr
Epigenomes 2 (2), 10, 2018
82018
Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities
B Caramelo, S Zagorac, S Corral, M Marqués, FX Real
European Urology Oncology 6 (4), 366-375, 2023
62023
Mutational landscapes of normal breast during age and pregnancy determine cancer risk
B Cereser, N Tabassum, LDB Belluz, A Yiu, S Zagorac, C Miere, B Werner, ...
bioRxiv, 2020.09. 04.277715, 2020
32020
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma
B Parejo-Alonso, A Royo-García, P Espiau-Romera, S Courtois, ...
Biomedicine & Pharmacotherapy 158, 114162, 2023
22023
The mutational landscape of the adult healthy parous and nulliparous human breast
B Cereser, A Yiu, N Tabassum, L Del Bel Belluz, S Zagorac, KRZ Ancheta, ...
Nature Communications 14 (1), 5136, 2023
12023
MicroRNA-mRNA interactions controlled by TGF-b
S Ottaviani, AF Frampton, M Chugh, P Dama, T Stiff, Q Liu, S Bayraktar, ...
Pancreatology 20 (8), e17, 2020
12020
Identification and functional characterization of epigenetic determinants of pancreatic CSCs
S Zagorac
12015
Vitamin D and pancreatic cancer
EL de Maturana, S Zagorac, N Malats, FX Real
Feldman and Pike's Vitamin D, 937-966, 2024
2024
ALK signaling drives tumorigenicity and chemoresistance of pancreatic ductal adenocarcinoma cells
B Parejo-Alonso, A Royo-García, P Espiau-Romera, S Courtois, ...
bioRxiv, 2022.08. 29.505637, 2022
2022
Abstract PD5-10: Mutational burden of the normal breast during age and pregnancy
B Cereser, N Tabassum, L Del Bel Belluz, S Zagorac, A Yiu, P Carter, ...
Cancer Research 81 (4_Supplement), PD5-10-PD5-10, 2021
2021
TGF-ß induces miR-100 and miR-125b but blocks let-7a to promote pancreatic cancer
S Ottaviani, AE Frampton, S Zagorac, J Stebbing, NR Lemoine, ...
Pancreatology 20 (8), e7-e8, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20